BI 1595043

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BI 1595043, covering 2024-02-21 to 2024-02-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food [Phase 1]